Animal diseases

SymCheck Releases COVID-19 Health Safety Compliance Platform Supporting Hospitality Industry Recovery

Retrieved on: 
Wednesday, February 10, 2021
Bat virome, Sarbecovirus, Severe acute respiratory syndrome, Infectious diseases, Medical specialties, Animal diseases

NEW YORK, Feb. 10, 2021 /PRNewswire-PRWeb/ -- SymCheck , an automated mobile health screening, assessment and compliance software platform, announced its commercial release today after several months of successful customer trials.

Key Points: 
  • NEW YORK, Feb. 10, 2021 /PRNewswire-PRWeb/ -- SymCheck , an automated mobile health screening, assessment and compliance software platform, announced its commercial release today after several months of successful customer trials.
  • "SymCheck automates everything I have to do to comply with the health department's screening and recordkeeping requirements for indoor dining.
  • SymCheck is an automated health screening, assessment and compliance software platform designed to verify that individuals do not pose an elevated risk for exposing others to illness.
  • SymCheck eliminates the required paperwork, prevents on-site exposure, protects personal health information and documents best practices to protect against SARS-CoV-2 or other transmission.

National Geographic Taps Harry Hamlin (“Mad Men,” “Shameless”) and Dylan Baker (“The Good Wife,” “Hunters”) as Guest Stars Alongside Previously Announced Leads Tony Goldwyn and Daniel Dae Kim for THE HOT ZONE: ANTHRAX

Retrieved on: 
Tuesday, February 9, 2021
Film & Motion Pictures, General Entertainment, Entertainment, Celebrity, TV and Radio, Council on Foreign Relations, Tom Brokaw, Anthrax, Brokaw, Animal diseases, Health, Television news in the United States

View the full release here: https://www.businesswire.com/news/home/20210209006062/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210209006062/en/
    Harry Hamlin will join the cast of THE HOT ZONE: ANTHRAX as Tom Brokaw, the respected journalist and anchor for NBC News.
  • Letters containing anthrax were sent to unsuspecting victims in Florida, Washington, D.C. and New York.
  • Despite interagency turf wars and many false leads, an unlikely team of scientists, FBI agents and government departments slowly closed in on a shocking prime suspect.
  • NGP returns 27% of our proceeds to the nonprofit National Geographic Society to fund work in the areas of science, exploration, conservation and education.

WHO COVID-19 Investigation Is Tainted by Conflict of Interest, Says AHF

Retrieved on: 
Tuesday, February 9, 2021
Infectious diseases, General Health, AIDS, Health, Jianghan Plain, Wuhan, Severe acute respiratory syndrome, Wet market, Infectious diseases, Medical specialties, Animal diseases

The institute is located just a few miles away from the wet market where Chinese authorities say SARS-CoV-2 first emerged.

Key Points: 
  • The institute is located just a few miles away from the wet market where Chinese authorities say SARS-CoV-2 first emerged.
  • For the WHO [World Health Organization] investigation in Wuhan to stand up to scientific scrutiny, neutrality is a must, said AHF President Michael Weinstein.
  • Dr. Daszak has a clear-cut conflict of interest that shouldve disqualified him from participation on the WHO team.
  • Now, any conclusions of the investigation will be tainted by one more fragment of uncertainty.

Phibro Animal Health Corporation to Participate in the Barclays Virtual Global Healthcare Conference

Retrieved on: 
Monday, February 8, 2021
Communications, Health, Other Health, General Health, Public relations, Investor relations, Veterinary, Animal diseases, Veterinary medicine, Veterinarian, Phibro, Barclays, Food, Companies, Service companies, Financial services

Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference.

Key Points: 
  • Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference.
  • The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com .
  • Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.
  • Our filings with the Securities and Exchange Commission are available online at www.sec.gov , www.pahc.com or on request from the company.

Ontario Proudly Invests in an “Airborne COVID-19 Detector” But is Still Denying the Virus Is Airborne; How Can This Be?

Retrieved on: 
Thursday, February 4, 2021
Public policy, Government, Practice Management, State, Local, Managed care, General Health, Health, Infectious diseases, Hospitals, Sarbecovirus, Respiratory diseases, Animal diseases, Coronavirus disease, Occupational safety and health, Zoonoses, Severe acute respiratory syndrome

CEM Specialties Inc. (CEMSI) will get $2 million through the Ontario Together Fund to help commercialize and accelerate production of an airborne COVID-19 detector.

Key Points: 
  • CEM Specialties Inc. (CEMSI) will get $2 million through the Ontario Together Fund to help commercialize and accelerate production of an airborne COVID-19 detector.
  • When the presence of the virus is detected the device provides an alert, the government media release says.
  • Further the media release states that the COVID-19 detection device continuously monitors the presence of the SARS-CoV-2 virus in the air.
  • Now they must apply this recognition of airborne transmission to policy especially in high-risk environments like long-term care homes and hospitals.

University Products LLC Comments on AG News America's Recent Survey Showing Preferences and Strategies to Help Ward-Off Anaplasmosis in U.S. Cattle - Including Prevention via Anaplasmosis Vaccine

Retrieved on: 
Thursday, February 4, 2021
Vaccination, Medical specialties, Anaplasmosis, Rickettsioses, Cattle, Vaccine, Dairy cattle, Animal diseases, Medicine

University Products, LLC is the maker and distributor of a bovine anaplasmosis vaccine successfully tested and deployed since 2000.

Key Points: 
  • University Products, LLC is the maker and distributor of a bovine anaplasmosis vaccine successfully tested and deployed since 2000.
  • CTC is a broad-spectrum antibiotic usually given in a variety of feeding levels and is used in beef cattle, non-lactating dairy cattle, and sheep.
  • While respondents using the other two methods continued to experience significant cattle loss , despite using CTC or testing.
  • For more information on the ongoing vaccine study, or vaccine availability for farmers and producers, contact Dr. Luther directly by email at [email protected] .

EmitBio Demonstrates New Treatment Is Effective Against Multiple Types Of Coronavirus

Retrieved on: 
Thursday, February 4, 2021
Coronaviridae, Sarbecovirus, Zoonoses, Animal diseases, Bat virome, In Saudi Arabia, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome, Coronavirus, Middle East respiratory syndrome–related coronavirus, Variants of SARS-CoV-2, Coronavir

These findings indicate a likelihood the company's technology will also be effective against SARS-CoV-2 variants (mutations).

Key Points: 
  • These findings indicate a likelihood the company's technology will also be effective against SARS-CoV-2 variants (mutations).
  • "Over the last 20 years we have seen three life-threatening coronavirus outbreaks, SARS-CoV-1, MERS-CoV, and now SARS-CoV-2 the virus that causes COVID-19," stated Neal Hunter, Executive Chairman of EmitBio.
  • "Having this countermeasure at-the-ready will not only help current COVID-19 patients but will also provide protection against future outbreaks.
  • The research team at EmitBio welcomes inquiries and offers of scientific collaboration from the global research community.

BioVaxys SARS-CoV-2 Vaccine Candidate BVX-0320 Stimulates Neutralizing Antibodies To Live COVID-19 Virus

Retrieved on: 
Tuesday, February 2, 2021
Sarbecovirus, Zoonoses, Animal diseases, Nidovirales, Bat virome, Severe acute respiratory syndrome, Severe acute respiratory syndrome coronavirus, Coronavirus disease, COVID-19 vaccine, Reporter virus particles

It's worth noting that OSU is one of the few institutions that has the laboratory capability to study live SARS-CoV-2 virus.

Key Points: 
  • It's worth noting that OSU is one of the few institutions that has the laboratory capability to study live SARS-CoV-2 virus.
  • Plaques are produced by infection of cultured human cells by a live SARS-CoV-2 virus.
  • For greater certainty, BioVaxys is not making any express or implied claims that it has the ability to treat the SAR-CoV-2 virus at this time.
  • BioVaxys has two issued US patents and two patent applications related to its cancer vaccine, and pending patent applications for its SARS-CoV-2 (Covid-19) vaccine and diagnostic technologies.

BioVaxys SARS-CoV-2 Vaccine Candidate BVX-0320 Stimulates Neutralizing Antibodies To Live COVID-19 Virus

Retrieved on: 
Tuesday, February 2, 2021
Sarbecovirus, Zoonoses, Animal diseases, Respiratory diseases, Bat virome, Severe acute respiratory syndrome, Coronavirus disease

It's worth noting that OSU is one of the few institutions that has the laboratory capability to study live SARS-CoV-2 virus.

Key Points: 
  • It's worth noting that OSU is one of the few institutions that has the laboratory capability to study live SARS-CoV-2 virus.
  • For greater certainty, BioVaxys is not making any express or implied claims that it has the ability to treat the SAR-CoV-2 virus at this time.
  • BioVaxys has two issued US patents and two patent applications related to its cancer vaccine, and pending patent applications for its SARS-CoV-2 (Covid-19) vaccine and diagnostic technologies.
  • BioVaxys common shares are listed on the CSE under the stock symbol "BIOV" and trade on the Frankfurt Bourse (FRA: 5LB) and US OTC: LMNGF.

SeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

Retrieved on: 
Thursday, January 28, 2021
Zoonoses, Sarbecovirus, Branches of biology, Animal diseases, Virology, Molecular biology, Laboratory techniques, Polymerase chain reaction, Variants of SARS-CoV-2, Coronavir, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome–related coronavirus

PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ -- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant.

Key Points: 
  • PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ -- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant.
  • The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control.
  • The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y assay does not require viral RNA extraction and has a rapid cycling protocol option, delivering sample to answer results in under 30'.
  • "The AzureSeq N501Y assay provides health officials, CLIA labs, and hospitals the ability to quickly identify and monitor this important SARS-CoV-2 variant," stated Joe Dunham, CSO of SeqOnce.